The deal involving Medicxi was based around six assets and completed at a premium to NAV, co-founder Francesco De Rubertis told Secondaries Investor.
2 min read · 23 September 2020
Managing director Jeff Pentland says the firm wants to start thinking about succession planning now rather than in a decade.
3 min read · 23 September 2020
The proportion of respondents who are ‘not concerned’ about liquidity was 81% across the summer, compared with 46% in the spring, according to a survey by the advisory firm.
1 min read · 22 September 2020
The US pension had set up a partnership with Pathway Capital Management last year to sell fund stakes.
2 min read · 17 September 2020
The $60bn US pension backed the Revelstoke and Accel-KKR GP-led deals last year and expects to invest in more before the year is out.
2 min read · 16 September 2020
The average high bid for buyout funds surpassed 90% of NAV in the three months to end-August, according to data from the intermediary.
2 min read · 14 September 2020
The SharesPost100 fund, designed to democratise access to VC, is managed by ex-HQ Capital secondaries co-head Christian Munafo.
2 min read · 14 September 2020
An apparent flurry of dealflow doesn’t mean they will all get across the line
2 min read · 10 September 2020
Strategies that worked well for buyers during the bull market may no longer work, says the investment firm’s head of secondaries Jeff Akers.
2 min read · 08 September 2020
Speaking at PEI’s virtual IR, Marketing & Communications Forum on Wednesday, a buyer said GPs may start to facilitate exits for LPs that want to streamline their portfolios.
2 min read · 03 September 2020
